104 related articles for article (PubMed ID: 3476764)
21. Phase I--II study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Kimura K; Yamada K; Uzuka Y; Maekawa T; Takaku F; Shimoyama M; Ogawa M; Amaki I; Osamura S; Ito M; Sakai Y; Oguro M; Hattori K; Hoshino A; Hirota Y; Ohta K; Nakamura T; Masaoka T; Kimura I; Ichimaru M
Recent Results Cancer Res; 1981; 76():232-40. PubMed ID: 7232852
[TBL] [Abstract][Full Text] [Related]
22. [Cytarabine].
Ota K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2983-7. PubMed ID: 3478003
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of acute myeloid leukemia with amsacrine and high-dose cytosine arabinoside: a phase II trial].
Marit G; David B; Reiffers J; Broustet A
Bull Cancer; 1985; 72(1):37-41. PubMed ID: 3857082
[TBL] [Abstract][Full Text] [Related]
24. Clinical use of intermediate to high dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in children with acute leukemia.
Takashima Y
J Clin Pharmacol; 1988 Apr; 28(4):356-62. PubMed ID: 3164731
[TBL] [Abstract][Full Text] [Related]
25. [Low-dose cytosine arabinoside (ARA-C) in the treatment of acute myeloid leukemia].
Beris P; Rieder A; Andrey C; Helg C; Chapuis B
Schweiz Med Wochenschr; 1984 Dec; 114(48):1763-6. PubMed ID: 6596706
[TBL] [Abstract][Full Text] [Related]
26. [Chemotherapeutic effects in hypoplastic leukemia].
Takahashi I; Nakada H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1209-14. PubMed ID: 3260089
[TBL] [Abstract][Full Text] [Related]
27. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
Karp JE; Passaniti A; Gojo I; Kaufmann S; Bible K; Garimella TS; Greer J; Briel J; Smith BD; Gore SD; Tidwell ML; Ross DD; Wright JJ; Colevas AD; Bauer KS
Clin Cancer Res; 2005 Dec; 11(23):8403-12. PubMed ID: 16322302
[TBL] [Abstract][Full Text] [Related]
28. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
[TBL] [Abstract][Full Text] [Related]
29. [A phase II study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC].
Kimura K
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2475-81. PubMed ID: 3619459
[TBL] [Abstract][Full Text] [Related]
30. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Roboz GJ; Ritchie EK; Curcio T; Provenzano J; Carlin R; Samuel M; Wittenberg B; Mazumdar M; Christos PJ; Mathew S; Allen-Bard S; Feldman EJ
Cancer; 2008 Nov; 113(9):2504-11. PubMed ID: 18825661
[TBL] [Abstract][Full Text] [Related]
31. Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy.
Rustum YM; Preisler HD
Cancer Res; 1979 Jan; 39(1):42-9. PubMed ID: 282940
[No Abstract] [Full Text] [Related]
32. [Efficacy and safety of induction chemotherapy consisting of anthracycline for 3 days and cytarabine for 7 days in elderly patients with acute myeloid leukemia].
Kurahashi S; Iwasaki T; Suzuki H; Sawamoto A; Sugimoto T; Narimatsu H; Adachi T; Hayakawa F; Sugiura I
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1617-21. PubMed ID: 17940376
[TBL] [Abstract][Full Text] [Related]
33. Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia.
Insiripong S; Thaisamakr S
J Med Assoc Thai; 1996 Sep; 79(9):568-71. PubMed ID: 8996985
[TBL] [Abstract][Full Text] [Related]
34. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
Tambone Reyes M; Bonaccorso R; Gebbia V; Tinnirello D; Di Salvo V; Ciulla A; Di Marco P; Mansueto S; Citarrella P
J Chemother; 1989 Jul; 1(4 Suppl):1276-8. PubMed ID: 16312864
[No Abstract] [Full Text] [Related]
35. Behenoyl cytarabine-associated reversible encephalopathy in a patient with acute myelogenous leukemia.
Cho SG; Moon H; Lee JH; Lee SY; Kim CC; Lee KS
J Korean Med Sci; 1999 Feb; 14(1):89-92. PubMed ID: 10102531
[TBL] [Abstract][Full Text] [Related]
36. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of acute non-lymphocytic leukemia with concurrent administration of N4-behenoyl-beta-D-arabinofuranosylcytosine, aclacinomycin A, 6-mercaptopurine and prednisolone; a pilot study (author's transl)].
Hirano M; Morishita Y; Ino T; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Saito M
Rinsho Ketsueki; 1981 Mar; 22(3):299-305. PubMed ID: 6944508
[No Abstract] [Full Text] [Related]
38. Phase I and early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies.
Takubo T; Tani Y; Kubota Y; Oguma S; Ueda T; Nakamura H; Shibata H; Masaoka T
Nihon Gan Chiryo Gakkai Shi; 1984 Feb; 19(1):1-7. PubMed ID: 6597236
[No Abstract] [Full Text] [Related]
39. [Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90].
Castaigne S; Archimbaud E; Fenaux P; Bordessoule D; Tilly H; Simon M; Dupriez B; Auzanneau G; Legros M; Tertian G
Nouv Rev Fr Hematol (1978); 1994 Jul; 36 Suppl 2():S139-40. PubMed ID: 7971262
[No Abstract] [Full Text] [Related]
40. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
Brunet S; Esteve J; Berlanga J; Ribera JM; Bueno J; Martà JM; Bargay J; Guardia R; Juliá A; Granena A; Montserrat E; Sierra J;
Haematologica; 2004 Aug; 89(8):940-9. PubMed ID: 15339677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
